
About Mani Agro chemicals
Mani Agro chemicals is a publicly listed company based in Indore (India) founded in 2006 by Rahul Pimpalkar. It provides agrochemicals, bio pesticides, fertilizers, and plant growth regulators for agriculture. It operates on a B2B model. The company has 3,256 employees. Its Indian entity Indiamart Intermesh Limited reported revenue of βΉ1,773 Cr. Mani Agro chemicals offers products and services including Insecticide Lambda Cyhalothrin, Bio Pesticide Mani Lava Plus, Super Potassium F Humate, Insecticide Profenofos 50 EC, and Herbicide Imazethapyr 10% SL. Its focus areas include Food and Agriculture Tech, Agrochemicals, Pesticides and Bio Pesticides.
Company details
Mani Agro Chemicals is a proprietorship firm based in Indore, India, specializing in processing, importing, and supplying agrochemicals. They offer products like bio organic fertilizers, bio pesticides, and soil conditioners to support agricultural needs. Their range includes insecticides, herbicides, and plant growth regulators, serving farmers and retailers with effective, pure chemicals for crop management and enhancement.
- Headquarters Indore, India
- Employees 3,256
- Founders Rahul Pimpalkar
- Stage Public
- SectorsAgriculture
- Phoneβ’β’β’β’ β’β’β’β’
- Website maniagrochemicals.com
- Legal Name Indiamart Intermesh Limited
- Date of Incorporation 13 Sep, 1999
- Jurisdiction New Delhi, Delhi, India
- Market Cap₹9,287 Cr
INDIAMART · NSE
- Share Price₹1,487.20
-3.69% today
- Revenue₹1,569 Cr
FY 2025-26 · +13.0% YoY
- EBITDA₹475 Cr
Margin 30.3%
- Net Profit₹475 Cr
FY 2025-26 · -10.1% YoY
- P/E (TTM)18.9x
P/B 4.1x
- ROE20.7%
ROCE 21.4%
- Debt / Equity0.01
Interest cover 0.7x
- Employee Count3,256
Associated legal entities of Mani Agro chemicals
Mani Agro chemicals operates through Indiamart Intermesh Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indiamart Intermesh Limited Listed CIN L74899DL1999PLC101534 | Active | 13 Sep 1999 | New Delhi, Delhi | ₹1,773 Cr | 3,793 | 10 | View details |
Products & Services of Mani Agro chemicals
Mani Agro chemicals offers a comprehensive portfolio of products and services, including Insecticide Lambda Cyhalothrin, Bio Pesticide Mani Lava Plus, Super Potassium F Humate, Insecticide Profenofos 50 EC, and Herbicide Imazethapyr 10% SL.
Pesticide for controlling insects in agricultural crops
Biological agent for managing pests in plants
Soil enhancer with potassium for improved plant growth
Chemical solution for pest control in farming
Weed control product for crop fields
Natural extract to boost plant health and yield
Board of directors of Indiamart Intermesh Limited (Mani Agro chemicals)
Indiamart Intermesh Limited is the primary company behind Mani Agro chemicals. The board of Indiamart Intermesh Limited currently have 8 directors; the longest-serving is Dinesh Chandra Agarwal, appointed in 1999. 19 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Chandra Agarwal DIN 00191800 | Managing Director | 13 Sep 1999 | 27 yrs 1 mo | Indiamart Intermesh Limited |
| Brijesh Kumar Agrawal DIN 00191760 | Whole-time director | 13 Sep 1999 | 27 yrs 1 mo | Indiamart Intermesh Limited |
| Vivek Narayan Gour DIN 00254383 | Director | 30 Apr 2018 | 8 yrs 6 mo | Indiamart Intermesh Limited |
| Pallavi Dinodia Gupta DIN 06566637 | Director | 20 Oct 2022 | 4 yrs | Indiamart Intermesh Limited |
| Manoj Bhargava DIN 08267536 | Whole-time director | 21 Jan 2025 | 1 yr 9 mo | Indiamart Intermesh Limited |
| Manish Vij DIN 00505422 | Director | 21 Jan 2025 | 1 yr 9 mo | Indiamart Intermesh Limited |
| Sandeep Kumar Barasia DIN 01432123 | Director | 29 Apr 2025 | 1 yr 6 mo | Indiamart Intermesh Limited |
| Vasuta Agarwal DIN 07480674 | Director | 18 Jul 2025 | 1 yr 3 mo | Indiamart Intermesh Limited |
People of Mani Agro chemicals
1 people are tracked at Mani Agro chemicals (1 in leadership); the tracked headcount is 3,256.
| Name | Role | Group |
|---|---|---|
Rahul Pimpalkar | Founder | Leadership |
Complete people profiles for Mani Agro chemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Mani Agro chemicals
Mani Agro chemicals is a publicly listed company on the NSE with ticker symbol INDIAMART in India, operating in the E-Commerce/App based Aggregator sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: INDIAMART
- Listed entityIndiamart Intermesh Limited
- Exchange sectorE-Commerce/App based Aggregator
Financials of Mani Agro chemicals
Exchange-reported figures of Indiamart Intermesh Limited, the listed company behind Mani Agro chemicals (NSE: INDIAMART).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,569 | 1,388 | 1,197 | 985 | 753 | 670 | 639 |
| Revenue growth | +13.0% | +16.0% | +21.5% | +30.8% | +12.5% | +4.8% | - |
| EBITDA | 475 | 474 | 289 | 230 | 296 | 326 | 167 |
| EBITDA margin | +30.3% | +34.1% | +24.2% | +23.3% | +39.2% | +48.6% | +26.2% |
| Profit before tax | 648 | 706 | 454 | 371 | 390 | 389 | 211 |
| Net profit | 475 | 528 | 335 | 283 | 297 | 279 | 147 |
| Net profit margin | +30.3% | +38.0% | +28.0% | +28.7% | +39.5% | +41.7% | +23.1% |
| EPS (βΉ) | 79.00 | 91.78 | 55.71 | 92.82 | 97.41 | 92.29 | 51.04 |
| Balance sheet | |||||||
| Total assets | 3,214 | 2,875 | 2,350 | 2,580 | 2,285 | 1,960 | 648 |
| Net worth | 2,400 | 2,185 | 1,736 | 2,058 | 1,874 | 1,611 | 275 |
| Total debt | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Cash & bank | 91.20 | 84.39 | 101 | 58.28 | 76.82 | 77.73 | 23.86 |
| Net working capital | (1,191) | (1,064) | (908) | (753) | (509) | (363) | (427) |
| Cash flow | |||||||
| Cash from operations | 694 | 623 | 559 | 476 | 402 | 322 | 261 |
| Cash from investing | (347) | (486) | 162 | (324) | (335) | (1,338) | (233) |
| Cash from financing | (340) | (148) | (695) | (143) | (57.52) | 1,038 | (51.30) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 429 | 414 | 404 | 402 | 391 | 372 | 355 | 354 |
| Revenue growth (YoY) | +9.6% | +11.4% | +13.9% | +13.4% | +12.5% | +12.3% | - | - |
| Other income | (7.60) | 107 | (33.90) | 135 | 10.20 | 92.40 | 109 | 44.90 |
| EBITDA | 144 | 132 | 120 | 120 | 116 | 119 | 119 | 124 |
| EBITDA margin | +33.6% | +31.8% | +29.7% | +29.8% | +29.7% | +32.1% | +33.6% | +35.1% |
| Depreciation | 6.40 | 6.40 | 7.00 | 7.30 | 7.20 | 6.90 | 8.30 | 8.30 |
| Interest | 0.50 | 0.50 | 0.60 | 0.70 | 0.70 | 1.00 | 1.70 | 1.80 |
| Profit before tax | 129 | 232 | 78.40 | 247 | 119 | 204 | 218 | 159 |
| Tax | 38.60 | 59.50 | 28.20 | 58.70 | 35.90 | 50.40 | 37.50 | 38.00 |
| Net profit | 90.80 | 172 | 50.20 | 188 | 82.70 | 154 | 181 | 121 |
| EPS (βΉ) | 15.05 | 28.56 | 8.33 | 31.24 | 13.71 | 25.52 | 30.06 | 20.13 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,443 | 1,320 | 1,139 | 939 | 751 | 665 | 624 |
| Revenue growth | +9.3% | +15.9% | +21.3% | +25.1% | +12.9% | +6.7% | - |
| EBITDA | 520 | 513 | 334 | 256 | 312 | 333 | 166 |
| EBITDA margin | +36.1% | +38.9% | +29.3% | +27.3% | +41.6% | +50.1% | +26.6% |
| Profit before tax | 694 | 773 | 475 | 345 | 403 | 396 | 210 |
| Net profit | 525 | 598 | 362 | 276 | 310 | 286 | 152 |
| Net profit margin | +36.4% | +45.3% | +31.8% | +29.4% | +41.2% | +43.0% | +24.4% |
| EPS (βΉ) | 87.41 | 101.20 | 60.42 | 89.01 | 101.41 | 94.57 | 50.63 |
| Balance sheet | |||||||
| Total assets | 3,310 | 2,934 | 2,342 | 2,549 | 2,303 | 1,966 | 647 |
| Net worth | 2,542 | 2,276 | 1,770 | 2,064 | 1,892 | 1,617 | 274 |
| Total debt | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Cash & bank | 77.38 | 68.94 | 81.37 | 50.28 | 72.56 | 72.61 | 19.77 |
| Net working capital | (1,141) | (1,021) | (898) | (741) | (513) | (368) | (430) |
| Cash flow | |||||||
| Cash from operations | 668 | 614 | 545 | 464 | 407 | 326 | 264 |
| Cash from investing | (347) | (492) | 181 | (316) | (339) | (1,343) | (236) |
| Cash from financing | (313) | (135) | (695) | (143) | (57.50) | 1,038 | (51.30) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 389 | 376 | 368 | 368 | 360 | 346 | 336 | 337 |
| Revenue growth (YoY) | +8.0% | +8.6% | +9.7% | +9.1% | +8.6% | +9.8% | - | - |
| Other income | (8.60) | 88.10 | (33.90) | 132 | 8.00 | 84.40 | 148 | 22.90 |
| Total expenses | 233 | 227 | 234 | 232 | 245 | 212 | 203 | 193 |
| EBITDA | 156 | 149 | 135 | 136 | 115 | 135 | 133 | 144 |
| EBITDA margin | +40.2% | +39.7% | +36.6% | +37.0% | +31.9% | +38.9% | +39.5% | +42.7% |
| Depreciation | 2.60 | 2.60 | 3.20 | 3.60 | 3.60 | 3.50 | 5.00 | 5.10 |
| Interest | 0.60 | 0.50 | 0.60 | 0.60 | 0.70 | 0.80 | 0.90 | 0.90 |
| Profit before tax | 145 | 234 | 96.90 | 264 | 119 | 215 | 275 | 161 |
| Tax | 38.30 | 58.20 | 27.30 | 58.00 | 35.20 | 48.80 | 43.60 | 36.00 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 429 | 414 | 404 | 402 | 391 | 372 | 355 | 354 |
| Revenue growth (YoY) | +9.6% | +11.4% | +13.9% | +13.4% | +12.5% | +12.3% | - | - |
| Other income | (7.60) | 107 | (33.90) | 135 | 10.20 | 92.40 | 109 | 44.90 |
| EBITDA | 144 | 132 | 120 | 120 | 116 | 119 | 119 | 124 |
| EBITDA margin | +33.6% | +31.8% | +29.7% | +29.8% | +29.7% | +32.1% | +33.6% | +35.1% |
| Depreciation | 6.40 | 6.40 | 7.00 | 7.30 | 7.20 | 6.90 | 8.30 | 8.30 |
| Interest | 0.50 | 0.50 | 0.60 | 0.70 | 0.70 | 1.00 | 1.70 | 1.80 |
| Profit before tax | 129 | 232 | 78.40 | 247 | 119 | 204 | 218 | 159 |
| Tax | 38.60 | 59.50 | 28.20 | 58.70 | 35.90 | 50.40 | 37.50 | 38.00 |
| Net profit | 90.80 | 172 | 50.20 | 188 | 82.70 | 154 | 181 | 121 |
| EPS (βΉ) | 15.05 | 28.56 | 8.33 | 31.24 | 13.71 | 25.52 | 30.06 | 20.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,569 | 1,388 | 1,197 | 985 | 753 | 670 | 639 |
| Revenue growth | +13.0% | +16.0% | +21.5% | +30.8% | +12.5% | +4.8% | - |
| Other income | 204 | 272 | 211 | 181 | 112 | 86.58 | 68.59 |
| Total expenses | 1,094 | 915 | 908 | 755 | 458 | 344 | 472 |
| Employee cost | 693 | 601 | 544 | 425 | 268 | 205 | 267 |
| EBITDA | 475 | 474 | 289 | 230 | 296 | 326 | 167 |
| EBITDA margin | +30.3% | +34.1% | +24.2% | +23.3% | +39.2% | +48.6% | +26.2% |
| Depreciation | 28.45 | 32.94 | 36.46 | 31.08 | 11.95 | 16.07 | 21.15 |
| Interest | 2.98 | 7.41 | 8.91 | 8.15 | 5.40 | 6.66 | 3.28 |
| Profit before tax | 648 | 706 | 454 | 371 | 390 | 389 | 211 |
| Tax | 173 | 155 | 120 | 87.45 | 92.83 | 110 | 64.04 |
| Net profit | 475 | 528 | 335 | 283 | 297 | 279 | 147 |
| Net profit margin | +30.3% | +38.0% | +28.0% | +28.7% | +39.5% | +41.7% | +23.1% |
| EPS (βΉ) | 79.00 | 91.78 | 55.71 | 92.82 | 97.41 | 92.29 | 51.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 60.08 | 60.01 | 59.95 | 30.58 | 30.55 | 30.32 | 28.88 |
| Reserves & surplus | 2,340 | 2,125 | 1,676 | 2,028 | 1,844 | 1,581 | 246 |
| Shareholders' funds (net worth) | 2,400 | 2,185 | 1,736 | 2,058 | 1,874 | 1,611 | 275 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Total debt | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Total liabilities | 3,214 | 2,875 | 2,350 | 2,580 | 2,285 | 1,960 | 648 |
| Assets | |||||||
| Gross block | 658 | 652 | 644 | 630 | 106 | 106 | 118 |
| Net block | 494 | 515 | 536 | 553 | 56.07 | 65.07 | 85.63 |
| Capital work in progress | 0.00 | 0.47 | 0.50 | 0.18 | 0.18 | 0.18 | 0.18 |
| Investments | 3,792 | 3,453 | 2,746 | 2,784 | 2,722 | 2,254 | 901 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 5.50 | 3.97 | 4.78 | 7.06 | 1.33 | 1.25 | 1.68 |
| Cash & bank balances | 91.20 | 84.39 | 101 | 58.28 | 76.82 | 77.73 | 23.86 |
| Loans & advances | 67.49 | 59.10 | 41.96 | 26.20 | 61.27 | 88.30 | 22.53 |
| Total current assets | 164 | 147 | 148 | 91.54 | 139 | 167 | 48.07 |
| Total current liabilities | 1,355 | 1,211 | 1,056 | 844 | 648 | 530 | 475 |
| Net working capital | (1,191) | (1,064) | (908) | (753) | (509) | (363) | (427) |
| Total assets | 3,214 | 2,875 | 2,350 | 2,580 | 2,285 | 1,960 | 648 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 73.48 | 84.80 | 58.11 | 49.55 | 40.12 | 16.94 | 40.20 |
| Net cash from operating activities | 694 | 623 | 559 | 476 | 402 | 322 | 261 |
| Net cash from investing activities | (347) | (486) | 162 | (324) | (335) | (1,338) | (233) |
| Net cash from financing activities | (340) | (148) | (695) | (143) | (57.52) | 1,038 | (51.30) |
| Net change in cash | 6.93 | (11.32) | 26.70 | 8.56 | 9.43 | 23.18 | (23.26) |
| Closing cash | 91.20 | 84.39 | 101 | 58.28 | 76.82 | 77.73 | 23.86 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +13.0% | +16.0% | +21.5% | +30.8% | +12.5% | +4.8% | - |
| EBITDA growth | +0.3% | +63.8% | +25.7% | -22.2% | -9.2% | +94.6% | - |
| PBT growth | -8.2% | +55.3% | +22.4% | -4.9% | +0.3% | +84.2% | +292.0% |
| Net income growth | -10.1% | +57.7% | +18.2% | -4.8% | +6.6% | +89.4% | - |
| Revenue CAGR (3Y) | +16.8% | +22.6% | +21.4% | +15.5% | +14.1% | +17.7% | +26.2% |
| EBITDA CAGR (3Y) | +27.4% | +17.0% | -3.9% | +11.2% | +158.6% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +30.3% | +39.7% | +27.9% | +28.8% | +39.5% | +41.8% | +23.1% |
| Return on capital employed | +21.4% | +27.3% | +18.8% | +15.6% | +18.7% | +27.8% | +26.3% |
| Return on net worth | +20.7% | +28.1% | +17.6% | +14.4% | +17.1% | +26.3% | +28.8% |
| Debt / equity | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.07 | 0.18 |
| Long-term debt / equity | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.06 | 0.14 |
| Interest cover | 0.67 | 1.68 | 3.53 | 4.10 | 1.90 | 2.15 | 2.24 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.39 | 2.14 | 1.88 | 2.68 | 7.09 | 5.98 | 9.24 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 331.37 | 317.33 | 202.16 | 234.90 | 584.10 | 457.04 | 567.87 |
| EPS (βΉ) | 79.00 | 91.78 | 55.71 | 92.82 | 97.41 | 92.29 | 51.04 |
| Dividend per share (βΉ) | 60.00 | 50.00 | 20.00 | 20.00 | 2.00 | 15.00 | 10.00 |
| Book value per share (βΉ) | 399.50 | 364.18 | 289.60 | 673.17 | 613.38 | 531.36 | 95.25 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 389 | 376 | 368 | 368 | 360 | 346 | 336 | 337 |
| Revenue growth (YoY) | +8.0% | +8.6% | +9.7% | +9.1% | +8.6% | +9.8% | - | - |
| Other income | (8.60) | 88.10 | (33.90) | 132 | 8.00 | 84.40 | 148 | 22.90 |
| Total expenses | 233 | 227 | 234 | 232 | 245 | 212 | 203 | 193 |
| EBITDA | 156 | 149 | 135 | 136 | 115 | 135 | 133 | 144 |
| EBITDA margin | +40.2% | +39.7% | +36.6% | +37.0% | +31.9% | +38.9% | +39.5% | +42.7% |
| Depreciation | 2.60 | 2.60 | 3.20 | 3.60 | 3.60 | 3.50 | 5.00 | 5.10 |
| Interest | 0.60 | 0.50 | 0.60 | 0.60 | 0.70 | 0.80 | 0.90 | 0.90 |
| Profit before tax | 145 | 234 | 96.90 | 264 | 119 | 215 | 275 | 161 |
| Tax | 38.30 | 58.20 | 27.30 | 58.00 | 35.20 | 48.80 | 43.60 | 36.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,443 | 1,320 | 1,139 | 939 | 751 | 665 | 624 |
| Revenue growth | +9.3% | +15.9% | +21.3% | +25.1% | +12.9% | +6.7% | - |
| Other income | 191 | 284 | 170 | 113 | 108 | 85.16 | 68.41 |
| Total expenses | 923 | 807 | 805 | 682 | 439 | 332 | 458 |
| Employee cost | 634 | 553 | 507 | 399 | 263 | 199 | 255 |
| EBITDA | 520 | 513 | 334 | 256 | 312 | 333 | 166 |
| EBITDA margin | +36.1% | +38.9% | +29.3% | +27.3% | +41.6% | +50.1% | +26.6% |
| Depreciation | 13.87 | 20.52 | 24.58 | 19.27 | 11.90 | 15.87 | 20.92 |
| Interest | 2.71 | 3.75 | 4.27 | 4.68 | 5.40 | 6.66 | 3.28 |
| Profit before tax | 694 | 773 | 475 | 345 | 403 | 396 | 210 |
| Tax | 169 | 166 | 112 | 73.11 | 92.83 | 109 | 63.78 |
| Net profit | 525 | 598 | 362 | 276 | 310 | 286 | 152 |
| Net profit margin | +36.4% | +45.3% | +31.8% | +29.4% | +41.2% | +43.0% | +24.4% |
| EPS (βΉ) | 87.41 | 101.20 | 60.42 | 89.01 | 101.41 | 94.57 | 50.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 60.08 | 60.01 | 59.95 | 30.58 | 30.55 | 30.32 | 28.88 |
| Reserves & surplus | 2,482 | 2,216 | 1,710 | 2,034 | 1,862 | 1,586 | 246 |
| Shareholders' funds (net worth) | 2,542 | 2,276 | 1,770 | 2,064 | 1,892 | 1,617 | 274 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Total debt | 23.10 | 33.04 | 40.67 | 45.91 | 56.28 | 63.42 | 76.51 |
| Total liabilities | 3,310 | 2,934 | 2,342 | 2,549 | 2,303 | 1,966 | 647 |
| Assets | |||||||
| Gross block | 134 | 133 | 131 | 117 | 105 | 105 | 116 |
| Net block | 20.88 | 33.26 | 47.38 | 53.19 | 56.03 | 64.99 | 85.22 |
| Capital work in progress | 0.00 | 0.00 | 0.50 | 0.18 | 0.18 | 0.18 | 0.18 |
| Investments | 4,326 | 3,944 | 3,199 | 3,224 | 2,745 | 2,267 | 906 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 1.12 | 1.68 | 1.35 | 1.58 | 1.33 | 1.25 | 1.10 |
| Cash & bank balances | 77.38 | 68.94 | 81.37 | 50.28 | 72.56 | 72.61 | 19.77 |
| Loans & advances | 30.44 | 32.91 | 27.43 | 18.63 | 59.80 | 87.12 | 20.94 |
| Total current assets | 109 | 104 | 110 | 70.49 | 134 | 161 | 41.81 |
| Total current liabilities | 1,250 | 1,125 | 1,009 | 812 | 647 | 529 | 472 |
| Net working capital | (1,141) | (1,021) | (898) | (741) | (513) | (368) | (430) |
| Total assets | 3,310 | 2,934 | 2,342 | 2,549 | 2,303 | 1,966 | 647 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 68.68 | 81.14 | 50.11 | 45.28 | 35.01 | 12.90 | 35.91 |
| Net cash from operating activities | 668 | 614 | 545 | 464 | 407 | 326 | 264 |
| Net cash from investing activities | (347) | (492) | 181 | (316) | (339) | (1,343) | (236) |
| Net cash from financing activities | (313) | (135) | (695) | (143) | (57.50) | 1,038 | (51.30) |
| Net change in cash | 8.38 | (12.46) | 31.03 | 4.83 | 10.27 | 22.10 | (23.01) |
| Closing cash | 77.38 | 68.94 | 81.37 | 50.28 | 72.56 | 72.61 | 19.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +9.3% | +15.9% | +21.3% | +25.1% | +12.9% | +6.7% | - |
| EBITDA growth | +1.3% | +53.8% | +30.2% | -17.9% | -6.4% | +101.1% | - |
| PBT growth | -10.2% | +62.9% | +37.5% | -14.3% | +1.7% | +88.6% | +353.1% |
| Net income growth | -12.2% | +65.4% | +31.3% | -11.0% | +8.3% | +88.2% | - |
| Revenue CAGR (3Y) | +15.4% | +20.7% | +19.6% | +14.6% | +14.7% | +18.1% | +26.4% |
| EBITDA CAGR (3Y) | +26.6% | +18.1% | +0.1% | +15.6% | +179.3% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +36.4% | +46.0% | +31.8% | +29.0% | +41.3% | +43.1% | +23.5% |
| Return on capital employed | +22.3% | +29.4% | +19.6% | +14.4% | +19.1% | +28.2% | +26.1% |
| Return on net worth | +21.8% | +30.0% | +18.9% | +13.8% | +17.7% | +26.9% | +28.7% |
| Debt / equity | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.07 | 0.18 |
| Long-term debt / equity | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.06 | 0.14 |
| Interest cover | 0.54 | 0.76 | 1.38 | 1.97 | 1.80 | 2.10 | 2.26 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 10.80 | 9.97 | 9.16 | 8.43 | 7.14 | 6.01 | 9.18 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 1,030.57 | 871.33 | 777.47 | 645.24 | 581.99 | 566.00 | 860.01 |
| EPS (βΉ) | 87.41 | 101.20 | 60.42 | 89.01 | 101.41 | 94.57 | 50.63 |
| Dividend per share (βΉ) | 60.00 | 50.00 | 20.00 | 20.00 | 2.00 | 15.00 | 10.00 |
| Book value per share (βΉ) | 423.03 | 379.33 | 295.31 | 675.11 | 619.30 | 533.26 | 95.06 |
Web traffic of Mani Agro chemicals
The website of Mani Agro chemicals (maniagrochemicals.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 7.9% vs previous month
Top companies in Insect Farming Tech
2 companies that operate in the same segment as Mani Agro chemicals (Insect Farming Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Insect-based nutrition products for animals and plants are produced. | 2021 | Delhi, Delhi, India | USD 4.19 M | 1 | ||
Insect-based proteins and biomaterials are developed for multiple industries. | 2019 | Bengaluru, Karnataka, India | USD 6.65 M | USD 103.14 K |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mani Agro Chemicals
Complete news archive for Mani Agro chemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Articles about Mani Agro chemicals on our blog
Frequently Asked Questions about Mani Agro chemicals
Mani Agro chemicals was founded in 2006.
Mani Agro chemicals is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Mani Agro chemicals has 3,256 employees.
The primary company behind Mani Agro chemicals, Indiamart Intermesh Limited, reported revenue of βΉ1,773 Cr for FY 2026, up 13% year on year.
Mani Agro Chemicals is a proprietorship firm based in Indore, India, specializing in processing, importing, and supplying agrochemicals. They offer products like bio organic fertilizers, bio pesticides, and soil conditioners to support agricultural needs. Their range includes insecticides, herbicides, and plant growth regulators, serving farmers and retailers with effective, pure chemicals for crop management and enhancement.
Mani Agro chemicals offers Insecticide Lambda Cyhalothrin, Bio Pesticide Mani Lava Plus, Super Potassium F Humate, Insecticide Profenofos 50 EC, and 2 more products and services.
Yes, Mani Agro chemicals is publicly traded on NSE under the ticker symbol INDIAMART.
Mani Agro chemicals operates through Indiamart Intermesh Limited.
The legal entities of Mani Agro chemicals currently have 9 directors, including Dinesh Chandra Agarwal, Brijesh Kumar Agrawal, Pallavi Dinodia Gupta and others.
